Pavia registry for people with primary cutaneous T-cell lymphoma
Official title: Local Registry of Primary Cutaneous T-cell Lymphomas
Run by Fondazione IRCCS Policlinico San Matteo di Pavia · NCT07160023 · Data updated 2026-11-12
This registry collects past and future medical information from people with primary cutaneous T-cell lymphoma who are seen at the Dermatology Clinic in Pavia to better understand treatments and outcomes.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 6 Years and up |
| Sex | All |
| Enrollment | 600 (estimated) |
| Sponsor | Fondazione IRCCS Policlinico San Matteo di Pavia Academic / other |
| Locations | 1 site (Pavia, Pavia) |
| Status | Recruiting |
| Started | October 12, 2023 |
| Main results expected | October 12, 2033 |
| Study ends | October 12, 2033 |
| Registry record updated | September 8, 2025 |
| Trial ID | NCT07160023 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Patients with a diagnosis of primary cutaneous T-cell lymphoma who attend the outpatient clinics of the Dermatology Unit at Fondazione IRCCS Policlinico San Matteo in Pavia are eligible.
✕Probably not a fit
Patients not treated or followed at the Pavia Dermatology Unit, as well as those with secondary skin involvement from systemic lymphoma or other diagnoses, are unlikely to benefit from this local registry.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This single-center registry will collect retrospective chart data and prospective clinical follow-up on patients diagnosed with primary cutaneous T-cell lymphoma who attend the Dermatology Unit at Fondazione IRCCS Policlinico San Matteo. Data collected will include demographics, disease subtype and stage, treatments received, response and adverse events, and timing of follow-up visits. Information will be entered from medical records and scheduled clinic visits into a standardized, de-identified database for descriptive analyses and to support future research. Participation does not change routine clinical care and is intended to improve local knowledge of disease course and management.
Why it matters
Potential benefit: If successful, the registry could help clinicians identify which treatments work best locally and guide improvements in patient care and future research.
How similar studies have gone: National and international registries for cutaneous T-cell lymphomas have previously provided useful epidemiologic and outcomes data, so this registry approach is established rather than novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion criteria: * primary cutaneous T-cell lymphoma attending the outpatient clinics of the Dermatology Unit in Pavia
Where it's running
-
SC Dermatologia, Fondazione IRCCS Policlinico San Matteo
Pavia, Pavia, Italy Recruiting
Study contacts
- Study coordinator: Valeria Brazzelli, MD
- Email: v.brazzelli@smatteo.pv.it
- Phone: 0382503794
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.